Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN: 161 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
161
Total FAERS Reports
4 (2.5%)
Deaths Reported
16
Hospitalizations
161
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities

Active Ingredient: EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN HYDROCHLORIDE ·

First Report: 20190601 · Latest Report: 20250501

What Are the Most Common EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN Side Effects?

#1 Most Reported
Blood glucose increased
29 reports (18.0%)
#2 Most Reported
Weight decreased
6 reports (3.7%)
#3 Most Reported
Vomiting
6 reports (3.7%)

All EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Blood glucose increased 29 18.0% 0 1
Feeling abnormal 6 3.7% 0 1
Glycosylated haemoglobin increased 6 3.7% 0 1
Headache 6 3.7% 0 1
Vomiting 6 3.7% 0 2
Weight decreased 6 3.7% 0 1
Blood glucose abnormal 5 3.1% 0 0
Diarrhoea 5 3.1% 0 2
Visual impairment 5 3.1% 0 1

Who Reports EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN Side Effects? Age & Gender Data

Gender: 45.5% female, 54.5% male. Average age: 63.2 years. Most reports from: US. View detailed demographics →

Is EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2019 1 0 0
2020 4 0 0
2021 17 0 6
2022 12 0 2
2023 19 2 0
2024 9 0 1
2025 1 0 0

View full timeline →

What Is EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN Used For?

IndicationReports
Product used for unknown indication 115
Type 2 diabetes mellitus 36
Diabetes mellitus 7

EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs Alternatives: Which Is Safer?

EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE\TENOFOVIR EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE/TENOFOVIR DISOPROXIL EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs EMTRICITABINE\TENOFOVIR DISOPROXIL EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs ENALAPRIL EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN vs ENALAPRIL\HYDROCHLOROTHIAZIDE

Official FDA Label for EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN

Official prescribing information from the FDA-approved drug label.